Aleksandra Gilis-Januszewska

10PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyPharmacology and pharmaceutical sciences not elsewhere classifiedCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 28, 2026
The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response?

Maria Komisarz-Calik, Anna Bogusławska, Aleksandra Gamrat-Żmuda

|Dec 20, 2025
Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results.

Beverly M K Biller, Aleksandra Gilis-Januszewska, Mirjana Doknic

|Mar 17, 2025
Pasireotide treatment in giant prolactinoma resistant to dopamine agonists.

Maria Komisarz-Calik, Grzegorz Zieliński, Karol Ciszek

|Jul 20, 2024
Patients with Cushing's syndrome suffer from provoked venous thromboembolism and are anticoagulated in various patterns.

Agata Hanna Bryk-Wiązania, Mari Minasyan, Alicja Hubalewska-Dydejczyk

|Jun 19, 2023
COVID-19 infection in a patient with Cushing's disease on osilodrostat treatment.

Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk

|Apr 11, 2023
Liquid levothyroxine in the treatment of myxoedema coma.

Grzegorz Sokołowski, Marcin Motyka, Aleksandra Gilis-Januszewska

Pageof 2

Frequent Collaborators

4 joint publications

Alicja Hubalewska-Dydejczyk

3 joint publications

Anna Bogusławska

2 joint publications

Mari Minasyan

2 joint publications

Maria Komisarz-Calik